GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare Technologies Inc. (NASDAQ:GEHC) formed a strategic collaboration with DeepHealth, a RadNet, Inc. (NASDAQ:RDNT) to advance AI in imaging.
GE醫療技術公司(納斯達克:GEHC)與DeepHealth達成戰略合作,以推動影像人工智能。
The companies aim to develop SmartTechnology solutions that leverage AI to improve imaging interpretation, reporting, clinical collaboration, and operational efficiency.
這些公司旨在開發利用人工智能的SmartTechnology解決方案,以改善影像解釋、報告、臨床協作和運營效率。
Under the agreement, GE HealthCare will distribute SmartMammo and other DeepHealth solutions to imaging providers across the U.S. as part of its comprehensive imaging technology portfolio.
根據協議,GE醫療將向美國各地的影像提供商分發SmartMammo和DeepHealth的其他解決方案,作爲其全面影像技術組合的一部分。
Beyond SmartMammo, the two companies plan to explore further collaboration on SmartTechnology solutions in other modalities and clinical domains, aiming to broaden access to and enhance the impact of AI-powered workflows.
除了SmartMammo,這兩家公司計劃在其他模式和臨床領域的SmartTechnology解決方案上進一步合作,旨在擴大人工智能工作流的使用範圍和影響力。
This collaboration aims to enhance breast cancer screening by integrating AI-driven clinical imaging support to improve detection and diagnosis during the critical early stages of treatment.
此次合作旨在通過整合人工智能驅動的臨床影像支持,改善乳腺癌篩查,提高在治療關鍵早期階段的檢測和診斷水平。
The collaboration between GE HealthCare and DeepHealth will also incorporate Smart Alerts, a DeepHealth workflow solution integrated with Senographe Pristina. This feature uses rapid AI processing to quickly identify potentially suspicious lesions, alerting imaging sites within minutes.
GE醫療和DeepHealth之間的合作還將整合Senographe Pristina的智能警報,這是一個集成了DeepHealth工作流解決方案的功能。該功能使用快速人工智能處理,可在幾分鐘內快速識別潛在可疑的病竈,並在警報後幾分鐘內提醒影像站點。
The goal is to enable same-day diagnostic exams, improve follow-up compliance, and reduce anxiety for women with potentially concerning findings.
目標是實現同日診斷檢查,改善後續遵從性,並減少對潛在有疑點病變的女性的焦慮。
Roland Rott, President & Chief Executive Officer of Imaging for GE HealthCare stated, "As we look to make more personalized, patient-centered breast care a reality – AI continues to show great promise in breast cancer screening from early detection and risk prediction, to reduced callbacks and more efficient workflows for breast imaging providers."
GE醫療影像總裁兼首席執行官Roland Rott表示:「隨着我們致力於實現更個性化、以患者爲中心的乳腺護理的願景- 人工智能在乳腺癌篩查方面繼續展現出巨大潛力,從早期檢測和風險預測,減少召回以及爲乳腺影像提供商提供更高效工作流。」
Investors can gain exposure to the stock via Spinnaker ETF Series Langar Global HealthTech ETF (NYSE:LGHT) and Invesco S&P Spin-Off ETF (NYSE:CSD).
投資者可以通過Spinnaker etf系列Langar全球醫療健康科技etf(紐約證券交易所代碼:LGHT)和景順標普分拆etf(紐約證券交易所代碼:CSD)獲得該股的曝光。
Price Action: GEHC shares are up 0.31% at $86.21 premarket at the last check Monday.
價格走勢:GEHC股價於上週一最後一次查看時盤前上漲0.31%,報86.21美元。
Image by PDPics from Pixabay
來自Pixabay的PDPics圖片
- GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI-Powered Future?
- GE Vernova Vs. GE Healthcare:押注電力還是醫療科技來引領人工智能驅動的未來?